Hoverink Biotechnologies, Inc. — Form D
Hoverink Biotechnologies, Inc. of LOS ANGELES, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-11-01. The offering totals $4.1M. Industry: Hospitals and Physicians.
Offering
- Filed: 2019-11-01
- Form: D
- Accession: 0001493152-19-016352
- Industry: Hospitals and Physicians
- Exemptions: 06b
- Total offering: $4.1M
- Remaining: $4.1M
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-352444
Issuer
- Name: Hoverink Biotechnologies, Inc.
- CIK: 0001586494
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 1801 PARK EAST 24TH FLOOR, LOS ANGELES, CA, 90067
- Phone: 866-443-4666
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Debbie Mae Carter | Director | Los Angeles, CA |
| Davidra Sajna | Director | LOS ANGELES, CA |
| Debbie Mae Carter | Executive Officer | Los Angeles, CA |
| Davidra Sajna | Executive Officer | LOS ANGELES, CA |
| Cyrus Sajna | Director | LOS ANGELES, CA |
| Cyrus Sajna | Executive Officer | LOS ANGELES, CA |
| Cyrus Sajna | Related Person | LOS ANGELES, CA |
| Davidra Nicole Sajna | Director | Los Angeles, CA |
| Davidra Nicole Sajna | Executive Officer | Los Angeles, CA |
| Davidra Sajna | Related Person | LOS ANGELES, CA |
| Debbie Carter | Director | LOS ANGELES, CA |
| Debbie Carter | Executive Officer | LOS ANGELES, CA |
| Debbie Carter | Related Person | LOS ANGELES, CA |
Other filings by this issuer (10)
More